Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Vendramin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Experimental Medicine|July 21, 2021
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanomaRoberto Vendramin, Vicky Katopodi, Sonia Cinque, et al.
Nature Machine Intelligence|May 28, 2026
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validationMarcellus Augustine, Nuno Rocha Nene, Hongchang Fu, et al.
Cancer Immunology Research|January 12, 2026
Training Tomorrow's Leaders in Cancer ImmunologyYuqi Tan, B J Kim, Adriana M Mujal, et al.
Nature|March 25, 2016
Melanoma addiction to the long non-coding RNA SAMMSONEleonora Leucci, Roberto Vendramin, Marco Spinazzi, et al.
Nature Communications|September 10, 2024
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stagesYue Zhao, Jian Gao, Jun Wang, et al.
Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Immunity|April 9, 2026
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidomeRoberto Vendramin, Hongchang Fu, Shanila Fernandez Patel, et al.
Cancer Cell|May 19, 2026
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Experimental Medicine|July 21, 2021
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanomaRoberto Vendramin, Vicky Katopodi, Sonia Cinque, et al.
Nature Machine Intelligence|May 28, 2026
Immunotherapy drug target identification using machine learning and patient-derived tumour explant validationMarcellus Augustine, Nuno Rocha Nene, Hongchang Fu, et al.
Cancer Immunology Research|January 12, 2026
Training Tomorrow's Leaders in Cancer ImmunologyYuqi Tan, B J Kim, Adriana M Mujal, et al.
Nature|March 25, 2016
Melanoma addiction to the long non-coding RNA SAMMSONEleonora Leucci, Roberto Vendramin, Marco Spinazzi, et al.
Nature Communications|September 10, 2024
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stagesYue Zhao, Jian Gao, Jun Wang, et al.
Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Immunity|April 9, 2026
Nonsense-mediated mRNA decay inhibition reshapes the cancer immunopeptidomeRoberto Vendramin, Hongchang Fu, Shanila Fernandez Patel, et al.
Cancer Cell|May 19, 2026
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 2